• Patients
    • Back
    • Patients
    • Restoring Brain Health
    • Understanding Brain Diseases
    • Neurology
      • Alzheimer's Disease
      • Lennox-Gastaut Syndrome
      • Migraine
      • Narcolepsy
      • Neuropathic Pain
      • Parkinson's Disease
      • Tourette's Syndrome
    • Psychiatry
      • Alcohol Use Disorder
      • Bipolar Disorder
      • Borderline Personality Disorder
      • Depression
      • Generalized Anxiety Disorder
      • Post-Traumatic Stress Disorder
      • Schizophrenia
  • Our Science
    • Back
    • Our Science
    • Research and Development
      • Our Value Chain
    • Products
    • Pipeline
    • Medical Education
      • Progress in Mind Resource Center
      • Lundbeck Institute
    • Clinical Trials
      • Clinical Trial Diversity
      • Study Synopses
    • Clinical Data Sharing
    • Publications
  • Stories
  • Sustainability
    • Back
    • Sustainability
    • Access To Brain Health
    • Climate Action
    • Donations And Grants
    • Health And Safety At Work
    • Materials Use And Waste
    • Responsible Business Conduct
    • Suppliers and Third Parties
    • Transparent Interactions
  • About Us
    • Back
    • About Us
    • Our Commitment
      • Diversity and Inclusion
      • Lundbeck’s position on Ukraine
    • Our Leadership
      • Executive Management
      • Board of Directors
    • This is Lundbeck
      • At a Glance
      • Organization and Ownership
      • The Lundbeck Foundation
      • Our History
    • Corporate Governance
      • Board Tasks
      • Remuneration
      • Risk Management
    • Our Strategy
  • Careers
    • Back
    • Careers
    • Life at Lundbeck
      • Our Culture and People
      • Being Diverse and Inclusive
      • Employee Development
    • Your Job
      • Job Opportunities
      • Career Areas
      • Recruitment Process
      • Unsolicited Applications
    • Early Career Programs
      • Students
      • Graduates
  • Investors
    • Back
    • Investors
    • Releases
      • Release Subscription
    • Financials
    • Reports and Presentations
      • Annual Reporting 2021
    • Events
      • Financial Calendar
      • General meeting
    • Investor Portal
    • The Share
      • Share Data
      • Shareholders and Dividends
      • Analyst Coverage
      • New Share Structure
    • Debt
  • Partnering
  • Press
  • Contact
  • Other Sites (Global)
    • Back
    • Global
      • Back
      • Global site
    • Africa
      • Back
      • South Africa
    • Americas
      • Back
      • Argentina
      • Bolivarian Republic of Venezuela
      • Brazil
      • Canada
      • Chile
      • Colombia
      • Mexico
      • Panama
      • Peru
      • United States
    • Asia
      • Back
      • China
      • Israel
      • Japan
      • Korea
      • Singapore
      • Turkey
    • Europe
      • Back
      • Austria
      • Belgium
      • Bulgaria
      • Czech Republic
      • Denmark
      • Estonia
      • Finland
      • France
      • Germany
      • Greece
      • Ireland
      • Italy
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Slovenia
      • Spain
      • Sweden
      • Switzerland
    • Oceania
      • Back
      • Australia/New Zealand
    • Other Sites
      • Back
      • Drughunters
      • Elaiapharm
      • Lundbeck Group Business Services
      • LUPI
    • Remote Support
  1. Home
  2. Investors
  3. The Share
  4. New Share Structure
  • Linkedin
  • Facebook
  • Email

Documents

Documents

  • Linkedin
  • Facebook
  • Email

Download

  • Listing Document (H. Lundbeck)
  • Summary Listing Document (H. Lundbeck)
  • 2022 Interim Financial Statement
  • 2021 Financial Statement
  • 2020 Financial Statement
  • 2019 Annual Report
  • Adjusted Supplementary Information to the Annual Report 2019
  • Articles of Association (ENG)
  • Draft Articles of Association (ENG)
  • Articles of Association (DK)
  • Draft Articles of Association (DK)
  • Form 8937 and Addendum

More from Lundbeck

Releases

Stay on top of the latest financial releases and developments from Lundbeck.

See Releases
Financials

An overview of Lundbeck’s financial performance. 

Read more
General Meeting

Documentation and information for stakeholders 

Read more

H. Lundbeck A/S

Ottiliavej 9
2500 Valby
Denmark

Headquarters

  • +45 3630 1311
  • info@lundbeck.com

Links

  • Report an Adverse Drug Reaction
  • Compliance Hotline
  • Terms of Use
  • Contact Us
  • Cookie Settings

Connect with us

Privacy Policy

Copyright© 2022 H. Lundbeck A/S